from Zero Hedge
As EU regulators push back against approving the Russian Gameleya Institute vaccine even after Hungary already kicked the doors open by becoming the first member of the block to approve it last week, Brussels is caught between a rock and a hard place. Even CNBC’s Jim Cramer, a long-time booster for western COVID vaccines, acknowledged during Wednesday morning’s premarket show that western consumers must accept that the Russian jab works.
Why? Because despite all the propaganda against the Gamaleya Institute, the Russian jab, first developed with the backing of the Russian sovereign wealth fund, has basically been proven effective by the latest report in the deeply respected Lancet, a scientific journal based in the UK that published some of the first international research on COVID-19.